Allogeneic Double Negative T Cells (DNT-UHN-1)

· University Health Network

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic Double Negative T Cells (DNT-UHN-1), covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of Allogeneic Double Negative T Cells (DNT-UHN-1) in Patients With High Risk Acute Myeloid Leukemia [Phase 1]

See pricing